This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
grants:start [2023/04/17 10:51] gustavsd [Table of grant numbers (last edited 4/6/2023)] |
grants:start [2025/02/27 15:13] (current) gustavsd |
||
---|---|---|---|
Line 36: | Line 36: | ||
| CAP | Foundation Grant | R01HD010333 | No | DeFries | | | CAP | Foundation Grant | R01HD010333 | No | DeFries | | ||
| | Age 7 | R01HD018426 | No | Fulker | | | | Age 7 | R01HD018426 | No | Fulker | | ||
- | | | Age 12-15 | MH43889 | + | | | Age 12-15 | R01MH043899 |
| | Later Adolescence-Adulthood | see CADD Wave 1-3 | No | | | | | Later Adolescence-Adulthood | see CADD Wave 1-3 | No | | | ||
| | Age 18-21 (ACE & cognition) | WT Grant Foundation | No | | | | | Age 18-21 (ACE & cognition) | WT Grant Foundation | No | | | ||
Line 49: | Line 49: | ||
| | Age 12-23 Mental Health | see CADD Wave 1-3 | No | | | | | Age 12-23 Mental Health | see CADD Wave 1-3 | No | | | ||
| | Age 16-23 Executive Function & Self-Regulation | R01MH063207 | No | Hewitt/ | | | Age 16-23 Executive Function & Self-Regulation | R01MH063207 | No | Hewitt/ | ||
+ | | | Age 21 Sleep | R01MH063207 | No | Friedman | | ||
| | Age 28 (LTS-MRI) | R01MH063207 | No | Friedman | | | | Age 28 (LTS-MRI) | R01MH063207 | No | Friedman | | ||
| | Age 28+ | see CATSLife | Yes | | | | | Age 28+ | see CATSLife | Yes | | | ||
| | | | | | ||
| CTS | Adolescent/ | | CTS | Adolescent/ | ||
+ | | | Sleep | R01MH063207 | No | Friedman | | ||
| | Executive Function & IQ | R01MH063207 & K01MH001865| No | Friedman & Young | | | | Executive Function & IQ | R01MH063207 & K01MH001865| No | Friedman & Young | | ||
| | | | | | ||
Line 61: | Line 63: | ||
| **Other Funding** | | | **Other Funding** | | ||
| ISG Workshop | Supports yearly ISG workshops | R25MH019918 | Yes | Keller (Prior: Hewitt) | | | ISG Workshop | Supports yearly ISG workshops | R25MH019918 | Yes | Keller (Prior: Hewitt) | | ||
+ | | | | ||
+ | | Ehringer Lab | Nicotine & Glial Expression | R21DA055781 | Yes | Ehringer/ | ||
+ | | | Opioid Use Disorders | U01DA051937 | Yes | Ehringer/ | ||
+ | | | | ||
+ | | Friedman Lab | Pain and Placebo Analgesia | R01DA046064 | Yes | Friedman/ | ||
+ | | | ABCD cohort | U01DA051018 | Yes | Banich/ | ||
+ | | | Alcohol | R01DA042742| Yes | Palmer | | ||
+ | | | | ||
+ | | Grotzinger Lab | Cognitive Change GWAS | RF1AG073593 | Yes | Grotzinger (subaward) | | ||
+ | | | | ||
+ | | Gustavson Lab | VETSA cohort analyses | R01AG050595 | Yes | Gustavson (subaward) | | ||
+ | | | VETSA cohort analyses | R03AG065643 | Yes | Gustavson | | ||
+ | | | | ||
+ | | Keller Lab | Parent/ | ||
+ | | | Psychiatric Disorders | R01MH100141 | Yes | Keller | | ||
+ | | | Rare Variants in Large Biobanks | R01DA044283 | Yes | Vrieze | | ||
+ | | | | ||
+ | | Stitzel Lab | Nicotine Behaviors | U01DA043802 | Yes | Stitzel/ | ||
+ | | | | ||
+ | | Willcut Lab | Learning Center | P50HD027802 | Yes | Banich (Prior: Olson, DeFries, Pennington) | | ||
Line 66: | Line 88: | ||
* CADD includes CAP (Age 17-25), LTS (Age 12-22), CTS, and Family Study assessments | * CADD includes CAP (Age 17-25), LTS (Age 12-22), CTS, and Family Study assessments | ||
+ | |||
+ | * CAP Extra Guidelines: All CAP papers should cite HD010333, the foundation CAP grant. | ||
+ | |||
+ |